Thai Pharmaceutical Manufacturers Association TPMA is the main association bringing together the local manufacturers in Thailand. What do you consider to have been the main milestones and achievements since your inception? We haven’t reached any milestones yet. Our first milestone will be to open and free the pharmaceutical market in Thailand by breaking the…
PREMA Thailand PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones and achievements of the organization? PReMA has been present in Thailand for 42 years. The association only changed and took…
Temis Lostaló Temis Lostaló was founded in 1968 by your father, Dr. Silvio Macchiavello. What have been the biggest challenges and opportunities of being a family owned company, and how have they affected the growth and development of the business? Lucila Macchiavello (LM): It’s fair to say that most family owned companies…
UNC-HEMODERIVADOS UNC HEMODERIVADOS tiene una estructura muy especial y única con su asociación con la Universidad de Córdoba. ¿Cual fue la visión cuando se creó la empresa? El Laboratorio UNC Hemoderivados es una dependencia de la Universidad Nacional de Córdoba, pero con características de autogestión. Durante muchos años costo definir el…
Massone What has been the history of Massone in Argentina and how has it changed since you took over the company? Since the creation of the company by my grandfather I am glad to say we have been very successful. My grandfather came to Argentina from a small town near Genoa…
Astellas Pharma Ltd. South Africa The South African affiliate was established in June 2003. Could you come back on the main milestones in the company’s development from 2003 onwards? Yamanouchi as an entity was an agency in South Africa under Pharmaplan from 1996. In 1997 I joined Pharmaplan as the Managing Director and ran the…
IMS Health Argentina It’s safe to assume that everywhere that IMS Health is established, there’s also a flourishing pharmaceutical industry. Could you give us an overview of Argentina’s IMS operations? IMS has been in Argentina for 35 years, working in information services. Two years ago, we started to offer our customers consulting services.…
ANMAT ¿Cual fue la visión de la creación de ANMAT y las circunstancias de su creación? En el momento de la creación del ANMAT, el Gobierno Nacional entendió las necesidades de tener un organismo regulador fuerte para el país y tener una apertura económica y comercial mucho más amplia. El resultado…
HLB Pharma Group Your entry into the Argentinean pharmaceutical market in 2004 was very unconventional, with your ‘holistic solution’ that had not been seen before in Argentina. Why was the time right in 2004 to start HLB Pharma? Hernán López Bernabó: We saw a special moment in Argentina to start a new company…
Bayer Schering Pharma Argentina The Bayer Schering merger in 2006 saw you add Argentina and Bolivia to your existing responsibilities as General Manager of Schering for Paraguay and Uruguay. What have been some of the challenges you have faced since that time? Argentina is a challenging market, and the system is very complex. This…
Pharma Dynamics In 2005, when Focus Reports interviewed you, you were more towards the start up phase of Pharma Dynamics; and you have significantly grown in the market since then. What new dimension has Pharma Dynamics today in the South African pharma market, and how have you integrated the company’s growth in…
IMS Health South Africa Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your personal country portfolio? For us, like many other multinationals (MNCs), South Africa remains a vibrant growth market. It is a country that we…
See our Cookie Privacy Policy Here
